UBQLN2 is on the X chromosome, and given the X-linked, dominant pattern of heritability of UBQLN2-mediated ALS/FTD [39], it is thought that mutation of UBQLN2 results in a toxic gain-of-function phenotype. The gene discussed is UBQLN2; the disease is frontotemporal dementia.